EKWCX
Price
$119.39
Change
+$3.67 (+3.17%)
Updated
Jun 12 closing price
Net Assets
1.2B
FKRCX
Price
$44.35
Change
+$1.50 (+3.50%)
Updated
Jun 12 closing price
Net Assets
3.06B
Interact to see
Advertisement

EKWCX vs FKRCX

Header iconEKWCX vs FKRCX Comparison
Open Charts EKWCX vs FKRCXBanner chart's image
EKWCX vs FKRCX Comparison Chart in %
View a ticker or compare two or three
VS
EKWCX vs. FKRCX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKWCX is a StrongBuy and FKRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FKRCX has more cash in the bank: 3.06B vs. EKWCX (1.2B). FKRCX pays higher dividends than EKWCX: FKRCX (9.93) vs EKWCX (0.46). EKWCX was incepted earlier than FKRCX: EKWCX (28 years) vs FKRCX (57 years). EKWCX (1.92) is less costly to investors than FKRCX (0.87). FKRCX is a more actively managed with annual turnover of: 22.76 vs. EKWCX (14.00). EKWCX (1000) and FKRCX (1000) have matching initial minimum investment requirements. FKRCX annual gain was more profitable for investors over the last year : 64.40 vs. EKWCX (50.83). EKWCX return over 5 years is better than : 148.97 vs. FKRCX (139.14).
EKWCXFKRCXEKWCX / FKRCX
Total Expense Ratio1.840.87211%
Annual Report Gross Expense Ratio1.920.87221%
Fund Existence28 years57 years-
Gain YTD-6.228-3.879161%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B3.06B39%
Annual Yield % from dividends0.469.935%
Returns for 1 year50.8364.4079%
Returns for 3 years191.36234.8181%
Returns for 5 years148.97139.14107%
Returns for 10 years232.60282.3382%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNDX18.250.34
+1.90%
Syndax Pharmaceuticals
BLUW10.31N/A
N/A
Blue Water Acquisition Corp III
BLRKU10.07N/A
N/A
Bluerock Acquisition Corp
QGEN37.06-0.36
-0.96%
Qiagen NV
PIII12.23-1.33
-9.77%
P3 Health Partners Inc